GE HealthCare Technologies Inc. logo
GEHCGE HealthCare Technologies Inc.

The market capitalization for GE HealthCare Technologies Inc. (GEHC) is $29.91 Billion, making it a Large Cap company. Market cap is calculated by multiplying the current stock price by the total number of shares outstanding.

Market Capitalization

$29.91B

$29.91 Billion

Calculation

Stock Price
$65.76
Shares Outstanding
454.89M
Market Cap
$29.91B

Market Cap = Price × Shares Outstanding

Size Classification

Large Cap

$10B - $1T

Companies with market capitalization between $10 billion and $1 trillion.

Market Cap Size Scale

Micro Cap

<$250M

Small Cap

$250M-$2B

Mid Cap

$2B-$10B

Large Cap

$10B-$1T

Mega Cap

>$1T

GEHC Market Cap: $29.91 Billion

Related Valuation Metrics

Key Statistics

Market Cap$29.91 Billion
Stock Price$65.76
Shares Outstanding454.89M
Size CategoryLarge Cap
P/E Ratio20.11
P/B Ratio2.82
Data as of Monday, June 29, 2026

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.

Chicago, IL
53,000 employees
Healthcare / Medical - Healthcare Information Services
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Peter J. Arduini